Faculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, 00232, Sierra Leone.
Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
BMC Health Serv Res. 2022 Nov 8;22(1):1327. doi: 10.1186/s12913-022-08606-x.
Antiretroviral therapy (ART) is the primary mode of treatment for Human Immunodeficiency Virus (HIV). It slows disease progression and reduces the spread of infection. HIV treatment is also known to require a high level of adherence of over 90% to achieve good treatment outcomes and viral load suppression. In Sierra Leone, about 70% of People Living with HIV (PLHIV) are non-adherent in their first year of treatment. Understanding the reasons behind this high rate of non-adherence from the perspectives of both PLHIV and health workers is critical for developing strategies to improve adherence. This qualitative study is rooted in the field of public health services. It identifies the barriers and facilitators influencing adherence to antiretroviral treatment in Sierra Leone. METHODS: A qualitative study design using in-depth interviews of four healthcare workers and 16 PLHIV in two districts in Sierra Leone- Freetown and Bo. The interviews were analyzed using a grounded theory approach to identify emerging themes from the data.
The study identified several facilitators and barriers to ART adherence at the personal, community, and health system levels. The facilitators included perceived benefits of ART, family support, having an informal caregiver, receiving free ART medicines, and belonging to peer support groups. The identified barriers were stigma and discrimination, frequency of medication, use of traditional medicine, lack of money for food and transport, work barriers, inadequate medicines and test kits, limited health workers, and long distances to clinics.
Our study emphasized the need for implementing behavioural change communication programmes and activities to reduce stigma and discrimination in the community. Knowledge of the facilitators and barriers to antiretroviral therapy could provide relevant information for more responsive and equitable programmes supporting adherence implementation in low- and middle-income countries. This study also identifies the vital need for community integration of HIV treatment services.
抗逆转录病毒疗法(ART)是治疗人类免疫缺陷病毒(HIV)的主要方式。它可以减缓疾病的进展并减少感染的传播。人们还知道,HIV 治疗需要超过 90%的高度依从性,才能取得良好的治疗效果和病毒载量抑制。在塞拉利昂,约 70%的 HIV 感染者在治疗的第一年不遵医嘱。从 HIV 感染者和卫生工作者的角度了解导致这种高不遵医率的原因,对于制定提高依从性的策略至关重要。这项定性研究植根于公共卫生服务领域,旨在确定影响塞拉利昂抗逆转录病毒治疗依从性的障碍和促进因素。
采用定性研究设计,对塞拉利昂弗里敦和博城两个地区的 4 名卫生工作者和 16 名 HIV 感染者进行了深入访谈。采用扎根理论方法对访谈进行分析,以从数据中识别出新兴主题。
研究确定了个人、社区和卫生系统层面上影响 ART 依从性的几个促进因素和障碍。促进因素包括对 ART 的益处的认知、家庭支持、有非正式照顾者、获得免费的 ART 药物以及参加同伴支持小组。确定的障碍包括耻辱感和歧视、药物频率、使用传统药物、缺乏食物和交通费用、工作障碍、药物和检测试剂盒不足、卫生工作者有限以及到诊所的距离远。
我们的研究强调需要实施行为改变沟通方案和活动,以减少社区中的耻辱感和歧视。了解抗逆转录病毒治疗的促进因素和障碍,可以为在低收入和中等收入国家支持依从性实施的更具响应性和公平性的方案提供相关信息。这项研究还确定了将 HIV 治疗服务融入社区的迫切需要。